EW

Edwards Lifesciences Corporation

Healthcare
90.82 +0.08 +0.09% Pre-Market
2026-09-02 • USD

Key Metrics

Market Cap 52.35B
EV 48.80B
Shares Out 576.40M
Revenue (ttm) 6.51B
Net Income 1.00B
Beta —
P/E —
Forward P/E —
EPS (ttm) $1.74
P/S 8.04
P/B 4.93
P/FCF 36.52
P/C 30.43
EV/Sales 7.49
EV/EBITDA 30.31
ROA 7.41%
ROE 9.65%
ROIC 8.83%
Gross Margin 77.84%
Oper. Margin 22.25%
Profit Margin 15.43%
Debt/Eq 0.07
LT Debt/Cap 5.34%
Quick Ratio 3.33
Current Ratio 4.52
Book/sh 18.42
Cash/sh 5.04
Div Yield —
Div TTM —
Payout Ratio —
SMA20 -0.21%
SMA50 1.33%
SMA200 6.97%
Volume 2,595,800
Avg Volume 4.57M
Rel Volume 0.57
Perf Week 0.88%
Perf Month 2.16%
Perf Quarter 5.51%
Perf Half Y 6.40%
Perf YTD 6.44%
Perf Year 11.72%
Perf 3Y 18.80%
Perf 5Y -25.05%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Edwards Lifesciences Corporation is the leading global structural heart innovation company driven by a passion to improve patient lives. Through breakthrough technologies,…

Name
Edwards Lifesciences Corporation
Industry
Medical Instruments & Supplies
CEO
Bernard Zovighian · Chief Executive Officer
Employees
16,000 as of 2025-12-31
IPO Date
2018-12-18
Phone
(949) 250-2500
Address
One Edwards Way, Irvine, CA 92614
Website
www.edwards.com

Key Executives

Name Title FY Pay
Bernard Zovighian Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.